249 related articles for article (PubMed ID: 31794352)
21. [Reference guide for the treatment of adult idiopathic thrombocytopenic purpura].
Kashiwagi H
Rinsho Ketsueki; 2020; 61(9):1325-1330. PubMed ID: 33162532
[TBL] [Abstract][Full Text] [Related]
22. Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
Al Askar AS; Shaheen NA; Al Zahrani M; Al Otaibi MG; Al Qahtani BS; Ahmed F; Al Zughaibi M; Kamran I; Mendoza MA; Khan A
Int J Hematol; 2018 Jan; 107(1):69-74. PubMed ID: 28895035
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
24. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
25. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
Pamuk ON; Ali SM; Hasni S
Autoimmun Rev; 2023 Apr; 22(4):103297. PubMed ID: 36781038
[TBL] [Abstract][Full Text] [Related]
26. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.
Lusa A; Carlson A
Lupus; 2018 Sep; 27(10):1723-1728. PubMed ID: 29673280
[TBL] [Abstract][Full Text] [Related]
28. Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia.
Zhang L; Jiao L; Wang SJ
Chin Med J (Engl); 2015 Sep; 128(18):2551-2. PubMed ID: 26365980
[No Abstract] [Full Text] [Related]
29. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
[TBL] [Abstract][Full Text] [Related]
30. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
31. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
Gall B; Yee A; Berry B; Bircham D; Hayashi A; Dansereau J; Hart J
J Obstet Gynaecol Can; 2010 Dec; 32(12):1167-1171. PubMed ID: 21176329
[TBL] [Abstract][Full Text] [Related]
32. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
[No Abstract] [Full Text] [Related]
33. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
Kikuchi K; Miyakawa Y; Ikeda S; Sato Y; Takebayashi T
BMC Health Serv Res; 2015 Jan; 15():2. PubMed ID: 25609557
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
Oved JH; Lee CSY; Bussel JB
J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
[TBL] [Abstract][Full Text] [Related]
35. Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers.
Waintraub SE; Brody JI
Semin Hematol; 2000 Jan; 37(1 Suppl 1):45-9. PubMed ID: 10676925
[TBL] [Abstract][Full Text] [Related]
36. Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
Jiang Y; Cheng Y; Ma S; Li T; Chen Z; Zuo X; Zhang X
J Autoimmun; 2022 Oct; 132():102887. PubMed ID: 36030136
[TBL] [Abstract][Full Text] [Related]
37. Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus.
Maruoka H; Koga T; Inoue Y; Honda S; Takeo M; Fukuda T; Aizawa H
Mod Rheumatol; 2007; 17(5):426-8. PubMed ID: 17929138
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
39. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
40. [Rituximab for treatment of patients with systemic autoimmune diseases].
García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
